These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 707953)

  • 1. [Pharmacokinetic profil of ketoprofen (author's transl)].
    Caillé G; Besner JG; Brodeur J; Vezina M
    Ann Pharm Fr; 1978; 36(5-6):243-52. PubMed ID: 707953
    [No Abstract]   [Full Text] [Related]  

  • 2. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of ketoprofen in patients with renal failure].
    Stafanger G; Larsen HW; Hansen H; Serensen K
    Sem Hop; 1983 Dec; 59(46):3191-3. PubMed ID: 6318338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels.
    Ballerini R; Casini A; Chinol M; Mannucci C; Giaccai L; Salvi M
    Int J Clin Pharmacol Res; 1986; 6(1):69-72. PubMed ID: 3957503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and therapeutic effects of ketoprofen.
    Sala G; Silvestri N; Castegnaro E; Pollini C
    Farmaco Prat; 1978 Oct; 33(10):455-60. PubMed ID: 312213
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of ketoprofen in the elderly.
    Advenier C; Roux A; Gobert C; Massias P; Varoquaux O; Flouvat B
    Br J Clin Pharmacol; 1983 Jul; 16(1):65-70. PubMed ID: 6882624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronokinetics of ketoprofen administered orally and by continuous venous infusion].
    Queneau P; Decousus H; Ollagnier M; Cherrah Y; Perpoint B; Hocquart J
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):403-8. PubMed ID: 4048810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The bioavailability of ketoprofen (Profenid) administered orally in combination with a gastric protector (aluminum phosphate, Phosphalugel)].
    Tamisier JN; Brazier JL; Ambert D; Bannier A
    Sem Hop; 1983 Dec; 59(46):3214-7. PubMed ID: 6318344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ketoprofen in patients with chronic renal failure.
    Stafanger G; Larsen HW; Hansen H; Sørensen
    Scand J Rheumatol; 1981; 10(3):189-92. PubMed ID: 7291952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of probenecid on ketoprofen kinetics.
    Upton RA; Williams RL; Buskin JN; Jones RM
    Clin Pharmacol Ther; 1982 Jun; 31(6):705-12. PubMed ID: 7075118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake and subcellular distribution of two non-steroidal anti-inflammatory drugs: indomethacin and ketoprofen.
    Blanchard JC; Schneider YJ; Tulkens P; Trouet A
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):4-16. PubMed ID: 507996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.
    Verbeeck RK; Wallace SM; Loewen GR
    Br J Clin Pharmacol; 1984 Jun; 17(6):783-4. PubMed ID: 6743473
    [No Abstract]   [Full Text] [Related]  

  • 17. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. IV. Ketoprofen disposition.
    Abas A; Meffin PJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):637-41. PubMed ID: 3806417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A controlled double-blind clinical trial of ketoprofen suppository in rheumatoid arthritis (author's transl)].
    Shichikawa K; Nobunaga T; Iwasaki T
    Ryumachi; 1982 Apr; 22(2):185-95. PubMed ID: 7051362
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro studies on the rates of intestinal absorption of sparsely soluble drugs of different particle size].
    Bramanti G; Mazzi G; Mura P; Pinzauti S; La Porta E; Papini P
    Boll Chim Farm; 1980 May; 119(5):267-74. PubMed ID: 7459048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.